Pirh2 has been demonstrated to function as an ubiquitin ligase that targets p53 for proteasome-mediated degradation. Pirh2 is also an androgen receptor (AR)-interacting protein and modulates the transcriptional activity of AR by regulating the levels of the AR corepressor, HDAC1, via ubiquitination.
Alternative names for
Pirh2 Antibody include h
RING finger and CHY zinc finger domain-containing protein 1 antibody,
Androgen receptor N-terminal-interacting protein antibody,
CH-rich-interacting match with PLAG1 antibody,
E3 ubiquitin-protein ligase
RING finger protein 199 antibody,
Zinc finger protein 363 antibody,
p53-induced RING-H2 protein antibody,
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase antibody,
zinc finger protein 363 antibody,
CH-rich interacting match with PLAG1 antibody,
p53-induced protein with a RING-H2 domain antibody,
androgen-receptor N-terminal-interacting protein antibody.